Register to receive a free Europe Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices report synopsis and brochure Rapid Medical, a company focused on the development of next generation neurovascular devices, has announced that it has received CE Mark approval for the TIGERTRIEVER 13. In addition, first patients have been treated successfully with the device.
iData ResearchRapid Medical Receives CE Mark Approval for TIGERTRIEVER 13
Register to receive a free U.S. Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices report synopsis and brochure The U.S. Food and Drug Administration today cleared the use of the Trevo clot retrieval device to treat certain stroke patients up to 24 hours after symptom onset, expanding the device’s indication to a broader group of
iData ResearchFDA Expands Treatment Window for Use of the Trevo Clot Retrieval Device In Certain Stroke Patients
The latest Vagus Nerve Stimulation Therapy® (“VNS Therapy”) System through LivaNova PLC features the recently FDA-approved SenTiva™ implantable generator, the smallest and lightest responsive therapy for epilepsy.
iData ResearchPhoenix Children’s Hospital is the First in Arizona to Offer New FDA Approved Epilepsy Treatment by LivaNova